BFRI
$0.48
Biofrontera
$.01
3.01%
BFRI
Earnings Whisper ®
N/A
2nd Quarter June 2023
Consensus:  ($0.24)
Revenue:  $7.10 Mil
Friday
Aug 11
8:45 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when BFRI reports earnings?
Beat
Meet
Miss

Where is BFRI's stock price going from here?
Up
Flat
Down
Stock chart of BFRI
Analysts
Summary of analysts' recommendations for BFRI
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Biofrontera Inc. is a biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on the fields of photodynamic therapy and topical antibiotics. The Company's licensed products focus on the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Biofrontera Inc. is based in WOBURN, MA.